13F

Stock

Regeneron Pharmaceuticals, Inc.

REGN · held by 11 managers

Reported value

$601.2M

Holders

11

+2 new · −2 exited

Holders’ est. mark

$60.2K

Price effect on 9 books still in the name

Largest holder

$433.9M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC412.7K$433.9M$73.5KAdded$65.9M
DANSKE BANK A/S69K$72.6M$14.2KAdded$1.42M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main41.3K$43.4M$10.7KCut−$4.95M
Marex Group plc35.2K$37MNew
Swiss Life Asset Management Ltd9.66K$10.2M−$3.32KAdded$1.78M
ONTARIO TEACHERS PENSION PLAN BOARD2.05K$2.16M$430Added$430
Leonteq Securities AG769$808.4K$161Added$4.37K
Emergent Wealth Advisors, LLC564$592.9K−$35.6KAdded$6.42K
Ramiah Investment Group467$490.9K$98Cut−$337.3K
Prestige Wealth Management Group LLC82$86.2K$18Cut−$21K
CHESAPEAKE ASSET MANAGEMENT LLC1$1.05KNew

Who left

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.